Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
2
×
boston blog main
boston top stories
2
×
clinical trials
life sciences
national blog main
abbvie
allergan
alzheimer's disease
antisense oligonucleotide
benzodiazepines
biogen
blackstone group
blackstone life sciences
columbia university
crispr
cynthia collins
david goldstein
deals
depression
editas medicine
epi4k
epilepsy
essential tremor
gene editing
investing
kiran reddy
leber congenital amaurosis type 10
major depressive disorder
marcio souza
michelle robertson
national top stories
new york blog main
new york top stories
parkinson's disease
perimenopausal depression
praxis precision medicines
ptc therapeutics
rare diseases
What
genetic
2
×
medicines
2
×
research
2
×
abbvie
aims
alliance
backed
biotech
cause
ceo
drugs
editas
editing
epilepsy
exits
experimental
gene
genes
links
marcio
mutations
neuro
new
pact
partnership
praxis
precision
pruning
returning
rights
souza
stop
terminated
treatment
turn
Language
unset
Current search:
genetic
×
boston
×
" boston top stories "
×
medicines
×
research
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
